NCT07479979
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- University of Wisconsin Madison, Wisconsin, United States
Clinical trial condition
Relapse Multiple Myeloma
Explore clinical trials studying Relapse Multiple Myeloma. Study availability and eligibility vary by location and protocol.
19 public trials
9 recruiting studies
Relapse Multiple Myeloma trial results
NCT07377435
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
NCT06799026
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Recruiting
Elranatamab in R/R Multiple Myeloma
NCT06138275
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Beth-Israel Deaconess Medical Center Boston, Massachusetts, United States
NCT07359014
- Conditions
- Relapse Multiple Myeloma
- Locations
-
- Xuzhao Zhang Hangzhou, China
NCT07093554
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Froedtert & the Medical College of Wisconsin Milwaukee, Wisconsin, United States
NCT05789303
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- University of Chicago Medicine Comprehensive Cancer Center Chicago, Illinois, United States
NCT06561854
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- Service d'hématologie clinique et thérapie cellulaire, Saint-Antoine Hospital Paris, France
NCT05243212
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Chaim Sheba Medical Center, Tel Hashomer Ramat Gan, Israel
Not Yet Recruiting
TAlquetamab and BeLantamab Mafodotin in Relapsed/Refractory Multiple Myeloma (TaBleMM)
NCT07720843
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +18 more
- Locations
-
Not specified